Aldeyra Therapeutics
ALDX
4,28 €
Share price
-0.80%
Change (1 day)
17.94%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €25.51 Million
According to Aldeyra Therapeutics 's latest financial reports the company's total liabilities are €25.51 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aldeyra Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €32.29 M | 25.11% |
| 2023-12-31 | €25.8 M | -8.58% |
| 2022-12-31 | €28.23 M | 16.68% |
| 2021-12-31 | €24.19 M | 24.81% |
| 2020-12-31 | €19.38 M | -20.85% |
| 2019-12-31 | €24.49 M | 230.67% |
| 2018-12-31 | €7.4 M | 94.29% |
| 2017-12-31 | €3.81 M | 13.34% |
| 2016-12-31 | €3.36 M | 10.56% |
| 2015-12-31 | €3.04 M | 47.82% |
| 2014-12-31 | €2.05 M | -49.67% |
| 2013-12-31 | €4.08 M | -80.06% |
| 2012-12-31 | €20.51 M | 927.09% |
| 2011-12-31 | €1.99 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | €7.03 B | 27,462.16% | 🇺🇸 USA |